Fortress Biotech Inc Pref Series A (FBIOP) net margin is -71.2%
Fortress Biotech Inc Pref Series A (FBIOP) net margin is -71.2% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full FBIOP research page for quote, filings, and the rest of the model. This satellite exists so “Fortress Biotech Inc Pref Series A net margin” can rank with the actual number, then send you to /stock/fbiop.